Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.53 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27540220 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL27681755 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL27532642 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL9820114 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL29009306 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL29265670 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL27437550 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL9711100 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL2039316 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR | |
| SCHEMBL27522465 | 1.00 | CDK1 (0.53) | CDK1CCNB1MEN1KMT2ATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2510100-A1 | MANNOSE-CONTAINING SOLUTION FOR LYOPHILIZATION, TRANSFECTION AND/OR INJECTION OF NUCLEIC ACIDS | Curevac GmbH (DE) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011069586-A1 | MANNOSE-CONTAINING SOLUTION FOR LYOPHILIZATION, TRANSFECTION AND/OR INJECTION OF NUCLEIC ACIDS | CUREVAC GMBH (DE) | 2011-06-16 | — | — | WO | disclosed |